Compare GRANULES INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA SUVEN PHARMACEUTICALS GRANULES INDIA/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x 16.5 43.3 38.2% View Chart
P/BV x 3.7 11.9 30.8% View Chart
Dividend Yield % 0.5 0.4 130.1%  

Financials

 GRANULES INDIA   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
SUVEN PHARMACEUTICALS
Mar-21
GRANULES INDIA/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs438525 83.4%   
Low Rs138103 134.2%   
Sales per share (Unadj.) Rs130.739.7 329.6%  
Earnings per share (Unadj.) Rs22.212.1 183.0%  
Cash flow per share (Unadj.) Rs28.313.4 211.7%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Avg Dividend yield %0.50.6 81.8%  
Book value per share (Unadj.) Rs86.846.4 187.2%  
Shares outstanding (eoy) m247.67254.57 97.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.27.9 27.8%   
Avg P/E ratio x13.025.9 50.1%  
P/CF ratio (eoy) x10.223.5 43.3%  
Price / Book Value ratio x3.36.8 49.0%  
Dividend payout %6.816.5 41.0%   
Avg Mkt Cap Rs m71,33779,953 89.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3,243762 425.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37510,097 320.6%  
Other income Rs m269142 188.8%   
Total revenues Rs m32,64410,240 318.8%   
Gross profit Rs m8,5524,430 193.1%  
Depreciation Rs m1,515316 478.8%   
Interest Rs m263117 225.3%   
Profit before tax Rs m7,0444,139 170.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5491,053 147.1%   
Profit after tax Rs m5,4953,086 178.0%  
Gross profit margin %26.443.9 60.2%  
Effective tax rate %22.025.4 86.4%   
Net profit margin %17.030.6 55.5%  
BALANCE SHEET DATA
Current assets Rs m19,9706,665 299.6%   
Current liabilities Rs m11,7313,215 364.9%   
Net working cap to sales %25.434.2 74.5%  
Current ratio x1.72.1 82.1%  
Inventory Days Days16200 8.2%  
Debtors Days Days863370 233.2%  
Net fixed assets Rs m17,1579,097 188.6%   
Share capital Rs m248255 97.3%   
"Free" reserves Rs m21,26211,554 184.0%   
Net worth Rs m21,51011,808 182.2%   
Long term debt Rs m3,411356 958.5%   
Total assets Rs m37,12715,762 235.5%  
Interest coverage x27.836.5 76.2%   
Debt to equity ratio x0.20 526.2%  
Sales to assets ratio x0.90.6 136.1%   
Return on assets %15.520.3 76.3%  
Return on equity %25.526.1 97.7%  
Return on capital %29.335.0 83.8%  
Exports to sales %81.90-   
Imports to sales %26.80-   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,5289,902 267.9%   
Fx outflow Rs m8,6911,369 634.9%   
Net fx Rs m17,8378,533 209.0%   
CASH FLOW
From Operations Rs m4,3253,834 112.8%  
From Investments Rs m-2,771-3,114 89.0%  
From Financial Activity Rs m-2,993-766 391.0%  
Net Cashflow Rs m-1,441-45 3,192.8%  

Share Holding

Indian Promoters % 41.6 60.0 69.4%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 25.7 14.2 181.4%  
FIIs % 21.4 8.3 259.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 40.0 145.1%  
Shareholders   216,385 86,447 250.3%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 19, 2022 03:35 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 5-YR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS